Video index

1. Call to order

2. Consideration of April 25, 2025, draft meeting minutes

3. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL.

5. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies andDURB members

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: OptumRx

8. Retrospective drug utilization review (DUR): Acentra Health

9. Prospective prior authorization proposals: Acentra Health

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program

11. Review of action items for next meeting: October 24, 2025, 9:00 a.m.

Jul 25, 2025 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order

2. Consideration of April 25, 2025, draft meeting minutes

3. Public comment and discussion on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL):

4. Public comment and discussion on single new drugs to be reviewed for the Medicaid PDL.

5. Therapeutic and clinical drug reviews and updates, discussion, and recommendations: Gainwell Technologies andDURB members

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: OptumRx

8. Retrospective drug utilization review (DUR): Acentra Health

9. Prospective prior authorization proposals: Acentra Health

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program

11. Review of action items for next meeting: October 24, 2025, 9:00 a.m.

© 2003-2025 Swagit Productions, LLC